SNPHF (Santen Pharmaceutical Co) PB Ratio : 1.82 (As of Dec. 15, 2024)

View and export this data going back to 2010. Start your Free Trial

What is Santen Pharmaceutical Co PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-12-15), Santen Pharmaceutical Co's share price is $10.532. Santen Pharmaceutical Co's Book Value per Share for the quarter that ended in Sep. 2024 was $5.79. Hence, Santen Pharmaceutical Co's PB Ratio of today is 1.82.

The historical rank and industry rank for Santen Pharmaceutical Co's PB Ratio or its related term are showing as below:

SNPHF' s PB Ratio Range Over the Past 10 Years
Min: 1.1 Med: 2.36 Max: 3.96
Current: 2.06

During the past 13 years, Santen Pharmaceutical Co's highest PB Ratio was 3.96. The lowest was 1.10. And the median was 2.36.

SNPHF's PB Ratio is ranked better than
51.81% of 940 companies
in the Drug Manufacturers industry
Industry Median: 2.075 vs SNPHF: 2.06

During the past 12 months, Santen Pharmaceutical Co's average Book Value Per Share Growth Rate was -1.10% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 2.80% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 2.60% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 5.80% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Santen Pharmaceutical Co was 15.50% per year. The lowest was 1.10% per year. And the median was 6.50% per year.

Back to Basics: PB Ratio

Santen Pharmaceutical Co PB Ratio Historical Data

The historical data trend for Santen Pharmaceutical Co's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Santen Pharmaceutical Co PB Ratio Chart

Santen Pharmaceutical Co Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

PB Ratio

Get a 7-Day Free Trial

2.41

1.96

1.61

1.48

1.68

Santen Pharmaceutical Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
PB Ratio	Get a 7-Day Free Trial															1.66	1.75	1.68	-	2.04

Competitive Comparison of Santen Pharmaceutical Co's PB Ratio

For the Drug Manufacturers - General subindustry, Santen Pharmaceutical Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Santen Pharmaceutical Co's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Santen Pharmaceutical Co's PB Ratio distribution charts can be found below:

* The bar in red indicates where Santen Pharmaceutical Co's PB Ratio falls into.

Santen Pharmaceutical Co PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Santen Pharmaceutical Co's PB Ratio for today is calculated as follows:

PB Ratio	=	Share Price	/	Book Value per Share (Q: Sep. 2024)
	=	10.532	/	5.79
	=	1.82

It can also be calculated from the numbers for the whole company:

PB Ratio

Market Cap

(Total Stockholders Equity

Preferred Stock)

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.

Santen Pharmaceutical Co (OTCPK:SNPHF) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.

Santen Pharmaceutical Co PB Ratio Related Terms

Thank you for viewing the detailed overview of Santen Pharmaceutical Co's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Santen Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Santen Pharmaceutical Co Ltd (OTCPK:SNPHF) » Definitions » PB Ratio

Comparable Companies

Traded in Other Exchanges

SNPHY:USA 4536:Japan SZD:Germany SZD:Germany

Address

Grand Front Osaka Tower A, 4-20 Ofuka-cho, Kita-ku, Osaka, JPN, 530-8552

Website

http://www.santen.co.jp

Santen Pharmaceutical Co Ltd is a drug manufacturing company that focuses on ophthalmic products. The company reports two primary operating segments: prescription ophthalmic pharmaceuticals and other. The pharmaceuticals segment includes over-the-counter pharmaceuticals, while the other segment includes medical devices. The vast majority of Santen's revenue is derived from its prescription ophthalmic pharmaceuticals segment, which manufactures and distributes prescription and OTC pharmaceuticals. Most of Santen's sales are generated in Japan, followed by other Asian countries.